Jenusaitis Matthew
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Jenusaitis Matthew. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NVNO | Purchase | 9,620 | $2.53 | $24,339 | Dec 19, 2024 | |
| NVNO | Option Exercise | 1,041 | — | — | Sep 13, 2022 | |
| NVNO | Option Exercise | 1,042 | — | — | Sep 13, 2021 | |
| NVNO | Purchase | 1,300 | $7.70 | $10,010 | Aug 25, 2021 | |
| NVNO | Award / Grant | 62,500 | — | — | Jul 18, 2020 | |
| 0001318310 | Sr VP & Pres, Neuro Division | Award / Grant | 30,000 | — | — | Apr 30, 2008 |
| 0001318310 | Sr. VP and Pres. Neuro. Div. | Sale | 1,086 | $15.00 | $16,290 | Nov 16, 2007 |
| 0001318310 | Sr VP & President, Neuro. Div. | Award / Grant | 16,447 | — | — | Oct 4, 2007 |
| 0001318310 | President, Neuro. Division | Award / Grant | 13,687 | — | — | Jan 22, 2007 |